SCHEMBL25928708

SCHEMBL25928708

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4sc5c(-c6cccc7c6sc6ccc(-n8c9ccccc9c9ccccc98)cc67)cccc5c4c3)n2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.38
KDM4E B2RXH2 1/20 0.34
ATM Q13315 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
LIMK1 P53667 1/20 0.33
PRKDC P78527 6/20 0.32
PIK3CD O00329 2/20 0.31
PIK3CB P42338 2/20 0.31
PARP14 Q460N5 1/20 0.31
ADORA2A P29274 1/20 0.31
ADORA1 P30542 1/20 0.31
PIM3 Q86V86 2/20 0.31
PIM1 P11309 1/20 0.30
PIM2 Q9P1W9 1/20 0.30
RAC2 P15153 1/20 0.30
RAC3 P60763 1/20 0.30
CDC42 P60953 1/20 0.30
RAC1 P63000 1/20 0.30
MEN1 O00255 1/20 0.30
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25928723 0.96 ALOX5 (0.41) ALOX5KDM4EATML3MBTL1LIMK1
SCHEMBL25928777 0.96 ALOX5 (0.41) ALOX5KDM4EATML3MBTL1LIMK1
SCHEMBL25928570 0.95 ALOX5 (0.38) ALOX5KDM4EATML3MBTL1LIMK1
SCHEMBL20922229 0.95 ALOX5 (0.36) ALOX5KDM4EATML3MBTL1LIMK1
SCHEMBL25928704 0.95 ALOX5 (0.38) ALOX5KDM4EATML3MBTL1LIMK1
SCHEMBL25714305 0.94 ALOX5 (0.41) ALOX5KDM4EATML3MBTL1LIMK1
SCHEMBL25928497 0.94 ALOX5 (0.36) ALOX5KDM4EATML3MBTL1LIMK1
SCHEMBL22329225 0.93 ALOX5 (0.38) ALOX5KDM4EATML3MBTL1LIMK1
SCHEMBL24232937 0.93 ALOX5 (0.35) ALOX5KDM4EATML3MBTL1LIMK1
SCHEMBL17231991 0.93 ALOX5 (0.36) ALOX5KDM4EATML3MBTL1LIMK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230247902-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-08-03 US disclosed
US-20230247902-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230247902-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE CRY1, PPOX, ORC3 ALOX5 959/4885KDM4E 2352/4885ATM 2148/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.